NCCN 2021 Conference Highlights: Elevating Racial Equity in Cancer Care
The National Comprehensive Cancer Network (NCCN) 2021 Annual Conference convened virtually March 18-20, drawing attendees from more than 40 countries...
2 min read
Gary Keeler : Jan 20, 2023 4:12:28 PM
It should come as no surprise that conducting a clinical trial is expensive. Just how expensive depends on the phase and design of the trial, with costs typically increasing with phase and complexity. A recent Tufts study has found that Phase III oncology trial budgets exceeded $65 million while non-oncology trial budgets were at ~$54 million. [1] Other sources have estimated even higher costs. [2]
Sponsors are interested in keeping their budgets stable and reigning in out-of-scope costs that can skyrocket budgets due to study changes, including delayed enrollment, protocol changes and erroneous initial budget estimates. What are some of the challenges and subsequent tips to keeping a trial on-time and within budget? Let’s start with upfront activities.
Trials that are outsourced to CROs for all or a portion of services can expect the service costs within the following categories, presented in descending order of a typical study budget:
Budgets are drawn up for activities within each of these areas, based on a near final protocol and comprise the ‘scope of work.’ A CRO will work with sponsors to develop a budget proposal based on an agreed upon scope of work. This can be a ballpark, preliminary estimate or a detailed appraisal with corresponding tasks and activities.
The National Comprehensive Cancer Network (NCCN) 2021 Annual Conference convened virtually March 18-20, drawing attendees from more than 40 countries...
Prediction: In 10 years, clinical trials will be nearly paperless. And clinical trial historians will note that the coronavirus pandemic was the...
First-in-Human studies are a discovery point, which can decide the fate of a compound as well as lay the groundwork for subsequent phases of a...